logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Moledina, Fatemah Ali
    Beautician born in January 1990
    Individual (5 offsprings)
    Officer
    icon of calendar 2015-09-23 ~ now
    OF - Director → CIF 0
    Mrs Fatemah Ali Moledina
    Born in January 1990
    Individual (5 offsprings)
    Person with significant control
    icon of calendar 2016-06-30 ~ now
    PE - Has significant influence or control → CIF 0
parent relation
Company in focus

NS PHARMA LIMITED

Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Intangible Assets
100,000 GBP2024-09-30
150,000 GBP2023-09-30
Fixed Assets
100,000 GBP2024-09-30
150,000 GBP2023-09-30
Total Inventories
50,570 GBP2024-09-30
42,570 GBP2023-09-30
Debtors
80,143 GBP2024-09-30
79,679 GBP2023-09-30
Cash at bank and in hand
49 GBP2024-09-30
61 GBP2023-09-30
Current Assets
130,762 GBP2024-09-30
122,310 GBP2023-09-30
Net Current Assets/Liabilities
-76,247 GBP2024-09-30
-70,789 GBP2023-09-30
Total Assets Less Current Liabilities
23,753 GBP2024-09-30
79,211 GBP2023-09-30
Net Assets/Liabilities
-350,574 GBP2024-09-30
-295,116 GBP2023-09-30
Equity
Called up share capital
2 GBP2024-09-30
2 GBP2023-09-30
Retained earnings (accumulated losses)
-350,576 GBP2024-09-30
-295,118 GBP2023-09-30
Average Number of Employees
22023-10-01 ~ 2024-09-30
22022-10-01 ~ 2023-09-30
Intangible Assets - Gross Cost
Net goodwill
500,000 GBP2024-09-30
500,000 GBP2023-09-30
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
400,000 GBP2024-09-30
350,000 GBP2023-09-30
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
50,000 GBP2023-10-01 ~ 2024-09-30
Intangible Assets
Net goodwill
100,000 GBP2024-09-30
150,000 GBP2023-09-30
Other types of inventories not specified separately
50,570 GBP2024-09-30
42,570 GBP2023-09-30
Trade Debtors/Trade Receivables
Current
44,488 GBP2024-09-30
47,943 GBP2023-09-30
Trade Creditors/Trade Payables
Current
55,913 GBP2024-09-30
Other Taxation & Social Security Payable
Current
84,280 GBP2024-09-30
59,256 GBP2023-09-30
Bank Borrowings/Overdrafts
Non-current
39,333 GBP2024-09-30
39,333 GBP2023-09-30
  • NS PHARMA LIMITED
    Info
    Registered number 09792259
    icon of address193 Edgware Road, London NW9 6LP
    Private Limited Company incorporated on 2015-09-23 (10 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2025-07-21
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 26 August 2025 and licensed under the Open Government Licence v3.0.